• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受无创性产前检测(NIPT)的女性在阳性非整倍体筛查后的情况。

Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.

机构信息

Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA.

出版信息

Prenat Diagn. 2013 Jun;33(6):542-6. doi: 10.1002/pd.4125.

DOI:10.1002/pd.4125
PMID:23592525
Abstract

OBJECTIVE

The aim of this study was to investigate how the introduction of noninvasive prenatal testing (NIPT) impacted women's testing choices following a positive prenatal screening (PNS) result.

METHODS

Beginning in March 2012, women referred to our Prenatal Diagnosis Center following a positive PNS result were offered NIPT or invasive prenatal diagnosis. Rates of invasive testing and declining follow-up were compared with testing decisions the prior year. Differences were compared using t-test and chi-square. Multivariable logistic regression was performed to identify predictors of test choice.

RESULTS

Between March 2012 and February 2013, 398 screen positive women were seen: 156 (39.2%) underwent invasive testing, 157 (39.4%) had NIPT and 84 (21.1%) declined further testing. In the prior year, 638 screen positive patients were seen: 301 (47.2%) had invasive testing and 337 (52.8%) declined. The rate of invasive testing declined significantly (p = 0.012). Moreover, fewer women declined follow-up testing after introduction of NIPT, 21.2% versus 52.8%, p ≤ 0.001. Race/ethnicity and timing of results (first versus second trimester) were predictors of testing choices; payer and maternal age were not.

CONCLUSION

The introduction of NIPT resulted in a significant decrease in invasive diagnostic testing. Additionally, fewer women declined further testing when NIPT was available.

摘要

目的

本研究旨在探讨非侵入性产前检测(NIPT)引入后对阳性产前筛查(PNS)结果后女性检测选择的影响。

方法

自 2012 年 3 月起,在阳性 PNS 结果后转诊至我们产前诊断中心的女性可选择 NIPT 或侵入性产前诊断。与前一年的检测决策相比,比较了侵入性检测和随访率的下降情况。使用 t 检验和卡方检验比较差异。采用多变量逻辑回归分析鉴定检测选择的预测因素。

结果

2012 年 3 月至 2013 年 2 月期间,共 398 名筛查阳性的女性就诊:156 名(39.2%)进行了侵入性检测,157 名(39.4%)进行了 NIPT,84 名(21.1%)拒绝进一步检测。前一年,共 638 名筛查阳性患者就诊:301 名(47.2%)进行了侵入性检测,337 名(52.8%)拒绝检测。侵入性检测率显著下降(p=0.012)。此外,引入 NIPT 后,拒绝进一步检测的女性比例明显下降,从 52.8%降至 21.2%,p≤0.001。种族/民族和结果时间(第一还是第二孕期)是检测选择的预测因素;支付方和产妇年龄不是。

结论

NIPT 的引入显著降低了侵入性诊断检测率。此外,当 NIPT 可用时,拒绝进一步检测的女性比例下降。

相似文献

1
Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.接受无创性产前检测(NIPT)的女性在阳性非整倍体筛查后的情况。
Prenat Diagn. 2013 Jun;33(6):542-6. doi: 10.1002/pd.4125.
2
Uptake of noninvasive prenatal testing at a large academic referral center.大型学术转诊中心对无创产前检测的接受情况。
Am J Obstet Gynecol. 2014 Dec;211(6):651.e1-7. doi: 10.1016/j.ajog.2014.06.038. Epub 2014 Jun 19.
3
Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.无创产前检测:对遗传咨询、侵入性产前诊断及21三体检测的影响
J Clin Ultrasound. 2015 Jan;43(1):1-6. doi: 10.1002/jcu.22243. Epub 2014 Oct 9.
4
The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.无创产前检测对母胎医学实践的影响。
Am J Perinatol. 2014 Oct;31(9):759-64. doi: 10.1055/s-0033-1359717. Epub 2013 Dec 11.
5
Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.非侵入性产前检测引入后胎儿非整倍体筛查的应用:一项全国基于人群的登记研究。
Acta Obstet Gynecol Scand. 2021 Jul;100(7):1265-1272. doi: 10.1111/aogs.14091. Epub 2021 Feb 9.
6
Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center.高危人群常规临床实践中的无创产前检测:来自一个中心的经验
Medicine (Baltimore). 2016 Oct;95(41):e5126. doi: 10.1097/MD.0000000000005126.
7
A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.韩国某城市三级医疗中心的非侵入性产前检测(NIPT)两年经验。
Taiwan J Obstet Gynecol. 2019 Jul;58(4):545-551. doi: 10.1016/j.tjog.2019.05.021.
8
Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.澳大利亚唐氏综合征的产前筛查:当前及新型筛查策略的成本与效益
Aust N Z J Obstet Gynaecol. 2013 Oct;53(5):425-33. doi: 10.1111/ajo.12136.
9
From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.从唐氏综合征筛查到无创产前检测:台湾地区20年经验
Taiwan J Obstet Gynecol. 2013 Dec;52(4):470-4. doi: 10.1016/j.tjog.2013.10.003.
10
Women's choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England.女性在非侵入性产前检测(唐氏综合征筛查)中的选择:英国引入前某单一中心的结果。
Arch Dis Child. 2020 Jan;105(1):47-52. doi: 10.1136/archdischild-2019-317031. Epub 2019 Jun 26.

引用本文的文献

1
Scoping review: the current landscape of NIPT in South Africa.综述:南非无创产前检测的现状
J Community Genet. 2025 May 28. doi: 10.1007/s12687-025-00802-6.
2
Effect of invasive tests during pregnancy on perinatal transmission of hepatitis B infection: a scoping review.孕期侵入性检查对乙型肝炎感染围产期传播的影响:一项范围综述
EClinicalMedicine. 2025 Jan 13;80:103039. doi: 10.1016/j.eclinm.2024.103039. eCollection 2025 Feb.
3
Patient Perceptions on the Advancement of Noninvasive Prenatal Testing for Sickle Cell Disease among Black Women in the United States.
美国黑人女性对无创性产前检测镰状细胞病进展的看法。
AJOB Empir Bioeth. 2024 Apr-Jun;15(2):154-163. doi: 10.1080/23294515.2024.2302996. Epub 2024 Feb 13.
4
Prenatal aneuploidy screening in a low-risk Hispanic population: price elasticity and cost-effectiveness.低风险西班牙裔人群的产前非整倍体筛查:价格弹性与成本效益
AJOG Glob Rep. 2023 Nov 18;4(1):100293. doi: 10.1016/j.xagr.2023.100293. eCollection 2024 Feb.
5
Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues.循环游离DNA筛查在孕期的应用拓展:当前及新出现的伦理、法律和社会问题
Curr Genet Med Rep. 2017 Mar;5(1):44-53. doi: 10.1007/s40142-017-0113-x. Epub 2017 Feb 11.
6
Challenges in the clinical understanding of genetic testing in birth defects and pediatric diseases.出生缺陷和儿科疾病基因检测临床理解方面的挑战。
Transl Pediatr. 2023 May 30;12(5):1028-1040. doi: 10.21037/tp-23-54. Epub 2023 May 4.
7
Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities.利用循环 DNA 和 RNA 的无创性产前检测:进展、挑战和可能性。
Annu Rev Biomed Data Sci. 2023 Aug 10;6:397-418. doi: 10.1146/annurev-biodatasci-020722-094144. Epub 2023 May 17.
8
Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.泰国一家三级医院的产前筛查检测与胎儿非整倍体的流行率。
PLoS One. 2023 Apr 20;18(4):e0284829. doi: 10.1371/journal.pone.0284829. eCollection 2023.
9
Non-Invasive prenatal testing with rolling circle amplification: Real-world clinical experience in a non-molecular laboratory.滚环扩增的无创性产前检测:非分子实验室的真实临床经验。
J Clin Lab Anal. 2023 Mar;37(6):e24870. doi: 10.1002/jcla.24870. Epub 2023 Mar 27.
10
Does an educational video for aneuploidy screening improve informed choice among pregnant women? A randomised controlled trial.是否有关于非整倍体筛查的教育视频可以改善孕妇的知情选择?一项随机对照试验。
Prenat Diagn. 2023 Jan;43(1):42-50. doi: 10.1002/pd.6279. Epub 2022 Dec 28.